Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Dolby
DLB
$5.77B
| $9.74M | ﹤0.01% |
138,129
+15,095
| +12% | +$1.04M |
|
2577
CALL
Monster Beverage
MNST
$88.7B
| $9.74M | ﹤0.01% |
+191,800
| New | +$9.29M |
|
2578
CALL
ScottsMiracle-Gro
SMG
$3.72B
| $9.72M | ﹤0.01% |
+200,000
| New | +$10M |
|
|
RPC
2579
Ridgepost Capital
RPC
$968M
| $9.71M | ﹤0.01% |
909,596
-62,823
| -6% | -$650K |
|
2580
Coursera
COUR
$1.52B
| $9.69M | ﹤0.01% |
819,207
-294,219
| -26% | -$3.71M |
|
2581
Dyne Therapeutics
DYN
$4.89B
| $9.69M | ﹤0.01% |
836,017
+438,447
| +110% | +$5.07M |
|
2582
DigitalBridge
DBRG
$2.95B
| $9.69M | ﹤0.01% |
885,428
-2,188,419
| -71% | -$28.4M |
|
|
CERE
2583
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $9.68M | ﹤0.01% |
306,950
+61,153
| +25% | +$1.73M |
|
2584
PUT
lululemon athletica
LULU
$14.4B
| $9.68M | ﹤0.01% |
+30,200
| New | +$9.93M |
|
2585
PC Connection
CNXN
$2.14B
| $9.67M | ﹤0.01% |
206,188
-3,327
| -2% | -$167K |
|
2586
Laureate Education
LAUR
$5.28B
| $9.67M | ﹤0.01% |
1,004,733
+210,437
| +26% | +$2.27M |
|
2587
CALL
Ferrari
RACE
$72.3B
| $9.64M | ﹤0.01% |
45,000
| – | – |
|
|
2588
PUT
Ferrari
RACE
$72.3B
| $9.64M | ﹤0.01% |
45,000
| – | – |
|
2589
Corcept Therapeutics
CORT
$11.9B
| $9.63M | ﹤0.01% |
474,201
+52,208
| +12% | +$1.31M |
|
2590
National Health Investors
NHI
$3.64B
| $9.63M | ﹤0.01% |
184,393
+59,255
| +47% | +$3.25M |
|
2591
Remitly
RELY
$5.14B
| $9.63M | ﹤0.01% |
840,722
-395,466
| -32% | -$4.1M |
|
2592
TechTarget
TTGT
$271M
| $9.62M | ﹤0.01% |
218,279
+90,181
| +70% | +$4.73M |
|
2593
Capitol Federal Financial
CFFN
$1.1B
| $9.62M | ﹤0.01% |
1,111,725
-468,860
| -30% | -$3.87M |
|
|
AVEO
2594
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $9.61M | ﹤0.01% |
642,652
+584,788
| +1,011% | +$8.1M |
|
2595
PUT
Shopify
SHOP
$193B
| $9.6M | ﹤0.01% |
276,700
+1,000
| +0.4% | +$34.1K |
|
|
2596
ScottsMiracle-Gro
SMG
$3.72B
| $9.59M | ﹤0.01% |
197,419
+21,748
| +12% | +$1.09M |
|
2597
PUT
Union Pacific
UNP
$174B
| $9.59M | ﹤0.01% |
46,300
-198,300
| -81% | -$40.7M |
|
2598
PUT
Upstart Holdings
UPST
$2.99B
| $9.58M | ﹤0.01% |
+725,000
| New | +$14M |
|
2599
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
| $9.58M | ﹤0.01% |
341,875
-128,817
| -27% | -$3.51M |
|
2600
CALL
Integra LifeSciences
IART
$1.33B
| $9.58M | ﹤0.01% |
+170,800
| New | +$8.69M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.